These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 11964533)

  • 1. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic.
    Lucas GM; Gebo KA; Chaisson RE; Moore RD
    AIDS; 2002 Mar; 16(5):767-74. PubMed ID: 11964533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.
    Palepu A; Horton NJ; Tibbetts N; Meli S; Samet JH
    Addiction; 2004 Mar; 99(3):361-8. PubMed ID: 14982549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol use accelerates HIV disease progression.
    Baum MK; Rafie C; Lai S; Sales S; Page JB; Campa A
    AIDS Res Hum Retroviruses; 2010 May; 26(5):511-8. PubMed ID: 20455765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group.
    Haubrich RH; Little SJ; Currier JS; Forthal DN; Kemper CA; Beall GN; Johnson D; Dubé MP; Hwang JY; McCutchan JA
    AIDS; 1999 Jun; 13(9):1099-107. PubMed ID: 10397541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection.
    Lucas GM; Cheever LW; Chaisson RE; Moore RD
    J Acquir Immune Defic Syndr; 2001 Jul; 27(3):251-9. PubMed ID: 11464144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions.
    Lucas GM; Chaisson RE; Moore RD
    Ann Intern Med; 1999 Jul; 131(2):81-7. PubMed ID: 10419445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women.
    Howard AA; Arnsten JH; Lo Y; Vlahov D; Rich JD; Schuman P; Stone VE; Smith DK; Schoenbaum EE;
    AIDS; 2002 Nov; 16(16):2175-82. PubMed ID: 12409739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort.
    Lesko CR; Tong W; Moore RD; Lau B
    AIDS Behav; 2017 Apr; 21(4):1016-1024. PubMed ID: 27752872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial.
    Laurent C; Kouanfack C; Laborde-Balen G; Aghokeng AF; Mbougua JB; Boyer S; Carrieri MP; Mben JM; Dontsop M; Kazé S; Molinari N; Bourgeois A; Mpoudi-Ngolé E; Spire B; Koulla-Shiro S; Delaporte E;
    Lancet Infect Dis; 2011 Nov; 11(11):825-33. PubMed ID: 21831714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of history of injection drug use and alcoholism on HIV disease progression.
    Lima VD; Kerr T; Wood E; Kozai T; Salters KA; Hogg RS; Montaner JS
    AIDS Care; 2014 Jan; 26(1):123-9. PubMed ID: 23767757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure.
    Merlin JS; Westfall AO; Raper JL; Zinski A; Norton WE; Willig JH; Gross R; Ritchie CS; Saag MS; Mugavero MJ
    J Acquir Immune Defic Syndr; 2012 Oct; 61(2):164-70. PubMed ID: 22766967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy.
    Palepu A; Tyndall MW; Li K; Yip B; O'Shaughnessy MV; Schechter MT; Montaner JS; Hogg RS
    J Urban Health; 2003 Dec; 80(4):667-75. PubMed ID: 14709714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.
    Braithwaite RS; Kozal MJ; Chang CC; Roberts MS; Fultz SL; Goetz MB; Gibert C; Rodriguez-Barradas M; Mole L; Justice AC
    AIDS; 2007 Jul; 21(12):1579-89. PubMed ID: 17630553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.
    Fox MP; Berhanu R; Steegen K; Firnhaber C; Ive P; Spencer D; Mashamaite S; Sheik S; Jonker I; Howell P; Long L; Evans D
    Trop Med Int Health; 2016 Sep; 21(9):1131-7. PubMed ID: 27383454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of use of alcohol and illicit drugs by AIDS patients on adherence to antiretroviral therapy in Bahia, Brazil.
    Teixeira C; Dourado Mde L; Santos MP; Brites C
    AIDS Res Hum Retroviruses; 2013 May; 29(5):799-804. PubMed ID: 23294471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-infected individuals who use alcohol and other drugs, and virologic suppression.
    Nolan S; Walley AY; Heeren TC; Patts GJ; Ventura AS; Sullivan MM; Samet JH; Saitz R
    AIDS Care; 2017 Sep; 29(9):1129-1136. PubMed ID: 28513200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
    Spacek LA; Shihab HM; Kamya MR; Mwesigire D; Ronald A; Mayanja H; Moore RD; Bates M; Quinn TC
    Clin Infect Dis; 2006 Jan; 42(2):252-9. PubMed ID: 16355337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study.
    Weber R; Huber M; Battegay M; Stähelin C; Castro Batanjer E; Calmy A; Bregenzer A; Bernasconi E; Schoeni-Affolter F; Ledergerber B;
    HIV Med; 2015 Mar; 16(3):137-51. PubMed ID: 25124393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.